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Abstract. 
 
Tumor necrosis factor–related apoptosis-
inducing ligand (TRAIL) –induced apoptosis, in trans-
formed human breast epithelial MCF-7 cells, resulted in 
a time-dependent activation of the initiator caspases-8 
and -9 and the effector caspase-7. Cleavage of caspase-8 
and its preferred substrate, Bid, preceded processing of 
caspases-7 and -9, indicating that caspase-8 is the apical 
initiator caspase in TRAIL-induced apoptosis. Using 
transient transfection of COOH-terminal–tagged green 
ﬂuorescent protein fusion constructs, caspases-3, -7, and 
-8 were localized throughout the cytoplasm of MCF-7 
cells. TRAIL-induced apoptosis resulted in activation 
of caspases-3 and -7, and the redistribution of most of 
their detectable catalytically active small subunits into 
large spheroidal cytoplasmic inclusions, which lacked a 
limiting membrane. These inclusions, which were also 
induced in untransfected cells, contained cytokeratins 8, 
18, and 19, together with both a phosphorylated form 
and a caspase-cleavage fragment of cytokeratin 18. 
Similarly, in untransfected breast HBL100 and lung 
A549 epithelial cells, TRAIL induced the formation of 
cytoplasmic inclusions that contained cleaved cyto-
keratin 18 and colocalized with active endogenous 
caspase-3. We propose that effector caspase-mediated 
cleavage of cytokeratins, resulting in disassembly of the 
cytoskeleton and formation of cytoplasmic inclusions, 
may be a characteristic feature of epithelial cell apop-
tosis.
Key words: Bid • caspase immunolocalization • epi-
thelial cells • intermediate ﬁlaments • K18
 
Introduction
 
Apoptosis is a process of fundamental importance to mul-
ticellular organisms that enables control of cell popula-
tions and the removal of damaged or potentially harmful
cells (Arends and Wyllie, 1991). Apoptosis occurs in two
phases: an initial commitment phase followed by an execu-
tion phase involving cytoskeletal disruption, membrane
blebbing, condensation and fragmentation of chromatin,
and the formation of apoptotic bodies (Earnshaw, 1995).
Caspases, a family of aspartate-specific cysteine proteases,
play a critical role in the execution phase of apoptosis and
are the key effectors responsible for many of the dramatic
morphological and biochemical changes of apoptosis (for
reviews see Cohen, 1997; Thornberry and Lazebnik, 1998).
Caspases are proteolytically cleaved at specific aspartate
residues, generating a large and small subunit that to-
gether form the active enzyme. Caspases can be divided
into two classes: (1) initiator caspases, with long pro-
domains, such as caspases-8 and -9, which either directly
or indirectly activate (2) effector caspases, such as cas-
pases-3, -6, and -7 (Srinivasula et al., 1996; Cohen, 1997;
Thornberry and Lazebnik, 1998). During the execution
phase of apoptosis, active effector caspases cleave intracel-
lular substrates including poly(ADP-ribose) polymerase
(Lazebnik et al., 1994) and the cytoskeletal components
actin (Kayalar et al., 1996) and lamins (Takahashi et al.,
1996).
Caspase-mediated proteolytic cleavage of lamins facili-
tates nuclear collapse, which is so widely used to distin-
guish apoptotic cells (Rao et al., 1996). More recently, it
has been reported that several type I and type II interme-
diate filament proteins, which comprise the acidic (K9–
K20) and basic cytokeratins (K1–K8) are dramatically re-
organized in cells during apoptosis (Caulin et al., 1997).
Cytokeratin 8 (K8)
 
1
 
 and cytokeratin 18 (K18) are the ma-
jor components of intermediate filaments in simple or sin-
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romethyl ketone. 
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gle layer epithelial tissues (Moll et al., 1982). Both K8 and
K18 are subject to posttranslational modification by phos-
phorylation (Ku and Omary, 1994). The reorganization of
K8/K18 filaments during apoptosis is associated with the
phosphorylation of K18 on serine 53 (previously referred
to as serine 52 relative to posttranslational processed pro-
tein; Ku and Omary, 1994). Furthermore, K18 is cleaved in
vitro by recombinant caspases, and such cleavage may ini-
tiate the orderly processing of filament proteins during
apoptosis (Caulin et al., 1997).
Triggering of the CD95 (Fas/APO-1) receptor with its
cognate ligand or agonistic antibody results in receptor
trimerization and recruitment of FADD/MORT1, which
in turn binds to the death effector domains of caspase-8,
resulting in its activation (Boldin et al., 1996; Muzio et al.,
1996). As caspase-8 activates all known caspases in vitro
(Srinivasula et al., 1996), it is a prime candidate for an
initiator caspase in many other forms of receptor-medi-
ated apoptosis. Mitochondria also have been proposed to
act as an amplifier in CD95-induced apoptosis with their
involvement being more important in certain cell types
(Kuwana et al., 1998; Scaffidi et al., 1998). Bid, a BH3 do-
main-containing proapoptotic Bcl-2 family member, is a
cytosolic substrate of caspase-8, which when cleaved,
translocates to the mitochondria where it induces the re-
lease of cytochrome 
 
c
 
 (Wang et al., 1996; Li et al., 1998;
Luo et al., 1998). In the presence of cytochrome 
 
c
 
, dATP,
and Apaf-1, procaspase-9 can act as an initiator caspase,
leading to the activation of the downstream effector cas-
pases-3, -6, and -7 (P. Li et al., 1997). It remains to be de-
termined whether this mitochondrial amplification loop,
activated after CD95 receptor engagement, is also involved
in other forms of receptor-mediated apoptosis.
Tumor necrosis factor–related apoptosis-inducing ligand
(TRAIL), like CD95, is a member of the tumor necrosis
factor (TNF) ligand family and induces apoptosis by bind-
ing to the receptors TR-1 (also called DR4) and TR-2
(also called DR5/TRICK-2/KILLER; for review see Ash-
kenazi and Dixit, 1998). Induction of apoptosis via this
pathway is thought to be mediated through caspase activa-
tion, although the caspases involved or their order of acti-
vation in intact cells has not been demonstrated clearly.
Regulation of TRAIL-induced apoptosis is, in part,
controlled by the relative levels of the death receptors
TR-1 and TR-2 and the decoy receptors TR-3 (also
called TRID/DcR1/LIT) and TR-4 (also called DcR2/
TRUNDD; Ashkenazi and Dixit, 1998). Specifically, ex-
pression of the decoy receptors in cell lines correlates, in
some instances, with resistance to TRAIL-induced apop-
tosis (Pan et al., 1997; Sheridan et al., 1997); thus, their rel-
ative levels may contribute to the reported selective cyto-
toxic potential of TRAIL in some tumors (Walczak et al.,
1999).
We, and others, have recently shown that distinct cas-
pase cascades are initiated during CD95-induced apopto-
sis (Scaffidi et al., 1998; Sun et al., 1999). We now demon-
strate that during TRAIL-induced apoptosis in MCF-7
cells, the initiator caspase-8 is activated at the apex of a
caspase cascade. Apoptosis induced in MCF-7, breast
HBL100 and lung A549 epithelial cells results in the for-
mation of spheroidal cytoplasmic inclusions. In HBL100
and A549 cells, these inclusions contain cleaved cytoker-
atins, which colocalize with active endogenous caspase-3.
Thus, sequestration of active effector caspases together
with cleaved cytokeratins in epithelial cells undergoing
apoptosis may facilitate the ordered dismantling of the fil-
ament network in epithelial cells during the execution
phase of apoptosis.
 
Materials and Methods
 
Materials
 
Media and serum were purchased from Life Technologies, Inc. The
caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl
ketone (z-VAD.FMK) and the caspase-3 substrate, benzyloxycarbonyl-
Asp-Glu-Val-Asp aminofluoromethyl coumarin (z-DEVD.AFC) were
purchased from Enzyme Systems Inc., and acetyl-Tyr-Val-Ala-Asp chlo-
romethyl ketone (YVAD.CMK) was purchased from Bachem. Anti-
CD95 mAb was obtained from Upstate Biotechnology Inc. The fluores-
cent probe MitoTracker™ red CMXRos was purchased from Molecular
Probes, Inc. All other chemicals and antibodies, unless stated otherwise,
were obtained from Sigma-Aldrich.
 
Generation of Expression Constructs
 
Full-length caspases-3 and -7, and caspase-8 C345A were synthesized by
PCR amplification and cloned into the pEGFP-N1 expression vector
(CLONTECH Laboratories, Inc.). The caspase-8 C345A encodes a protein
with a cysteine to alanine mutation at its active site to partially inhibit the
cell killing induced by autoprocessing of exogenously expressed caspase-8.
PCR was performed using Expand™ High Fidelity (Boehringer Mann-
heim) to minimize errors, and the products were purified and digested with
 
restriction enzymes (GIBCO BRL, Life Technologies, Inc.). PCR primers
were designed so that a restriction enzyme site was introduced before the
start and stop codons with GFP tagged in-frame at the COOH terminus of
the expressed caspase. The fragments were ligated into the BamHI and
XhoI sites (caspases-3 and -7), or the HindIII and XhoI sites (caspase-8) of
pEGFP-N1 and all constructs were confirmed by sequencing.
 
Cell Culture, Transient Transfection, and 
Quantification of Apoptosis
 
MCF-7-Fas (MCF-7) human breast epithelial cells (provided by Dr. M
Jattella, Danish Cancer Society Research Center, Copenhagen, Denmark)
were grown in RPMI 1640 supplemented with 10% FBS and 2 mM
Glutamax™. HBL100 human breast epithelial cells and A549 human lung
type II pneumocytes (both obtained from European Collection of Animal
Cell Cultures) were grown in DME supplemented with 10% FBS. The
cells were cultured in an atmosphere of 5% CO
 
2
 
 in air at 37
 
8
 
C and main-
tained in logarithmic growth phase by routine passage every 3–4 d. Cells
were plated at a density of 2 
 
3
 
 10
 
5
 
 cells per well in 6-well dishes and 2 d
later, were transiently transfected either using Lipofectamine (GIBCO
BRL) or Fujene™ 6 (Boehringer Mannheim) according to the manufac-
turer’s instructions, using between 2 and 4 
 
m
 
g DNA for each transfection.
 
Where indicated, cells were treated at the time of transfection with z-VAD.
 
FMK (10–50 
 
m
 
M) or YVAD.CMK (10–50 
 
m
 
M). At 16–24 h after trans-
fection, cells were treated with 1 
 
m
 
g/ml  recombinant soluble TRAIL
(MacFarlane et al., 1997a) or 100 ng/ml anti-CD95 for the indicated times
and apoptosis quantified by phosphatidylserine exposure using Annexin
V-PE (PharMingen). MCF-7 cell lysates were prepared as described pre-
viously (MacFarlane et al., 1997b) and activated by the addition of 2 mM
dATP, 0.25 mg/ml cytochrome 
 
c
 
, and 2 mM MgCl
 
2
 
. The proteolytic activ-
ity (cleavage of z-DEVD.AFC) of the lysate was measured as described
previously (MacFarlane et al., 1997b).
 
Cell Sorting
 
MCF-7 cells were transfected with EGFP-tagged caspase-7 and, 48 h after
transfection, the cells were treated with 1 
 
m
 
g/ml TRAIL for 5 h at 37
 
8
 
C.
The medium was removed and spun down at 200 
 
g
 
 for 3 min at 4
 
8
 
C to col-
lect any apoptotic cells that had become detached from the plate. The re-
maining attached cells were collected by trypsinization and the detached
and adherent cells were pooled, spun down, washed in ice-cold PBS, and
 
resuspended in 5 ml ice-cold PBS. The cells were sorted on a FACS
 
Ò
 
 Van- 
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tage (Becton Dickinson), and populations of cells exhibiting low or high in-
tensity green fluorescence were collected for analysis by Western blotting.
 
Gel Electrophoresis and Immunoblotting
 
Equal numbers of cells were lysed in SDS-PAGE buffer and separated on
10% (GFP, K8, and K19) or 12% (caspases, Bid, and K18) SDS-polyacryl-
amide gels, followed by electrophoretic transfer onto nitrocellulose (Hy-
bond-C extra; Amersham) as previously described (MacFarlane et al.,
1997b). Equal protein loading per lane was verified by staining the mem-
branes with 0.1% Ponceau S. Immunodetection was carried out using the
enhanced chemiluminescence detection system (Amersham) according to
the manufacturer’s instructions.
 
Primary Antibodies
 
Antibodies to caspase-3 (from Dr. D. Nicholson, Merck Frosst, Quebec,
Canada), caspases-7, -8, and -9 (provided by Dr. D. Green, Institute for
Allergy and Immunology, La Jolla, CA), and Bid (from Dr. X. Wang,
University of Texas Southwestern Medical Center, Dallas, TX) were used
for Western blot analysis, as previously described (Sun et al., 1999). The
rabbit polyclonal antibody CM1, specific for the p18 subunit of activated
caspase-3 (Srinivasan et al., 1998; provided by IDUN, La Jolla, CA), was
used at a 1:2,500 dilution for fluorescence immunocytochemistry. The rab-
bit polyclonal antibody to GFP was obtained from CLONTECH Labora-
tories, Inc., and used at a 1:2,000 dilution for immunoblotting. The mouse
mAb M20, specific for K8, and A53-B/A2, specific for K19, were both
used at a 1:10,000 dilution for Western blotting, at 1:250 for fluorescence
immunocytochemistry and at 1:5–1:100 for ultrastructural immunocy-
tochemistry. The 3055 rabbit polyclonal antibody, specific for K18 phos-
phorylated on serine 53 (Liao et al., 1995; provided by Dr. B. Omary,
Stanford University School of Medicine, Stanford, CA), was used at 1:10,000
for immunoblotting, at 1:250 for fluorescence immunocytochemistry, and
at 1:100 for ultrastructural immunocytochemistry. The CY-90 mouse
mAb, specific for K18, was used at a 1:20,000 dilution for immunoblotting,
1:500 for fluorescence immunocytochemistry, and 1:200 for ultrastructural
immunocytochemistry. The mouse mAb, M30 (Boehringer Mannheim),
which specifically detects a caspase cleavage site in K18 at DALD
 
397
 
¯
 
S
(Leers et al., 1999), was used at 1:200 for fluorescence immunocyto-
chemistry and at 1:100 for ultrastructural immunocytochemistry. The
M30 antibody specifically labels apoptotic epithelial cells and does not
label viable or necrotic cells (Leers et al., 1999). The calnexin antibody,
clone calnexin-CT (Stressgen Biotechnology Corp.), was used at a dilution
of 1:100 for fluorescence immunocytochemistry. The mAbs, clone 6-11B-1,
to acetylated tubulin, clone AC15, specific for 
 
b
 
-actin and clone Vim3B4,
to vimentin (Boehringer Mannheim) were also used.
 
Immunofluorescence Microscopy
 
Cells were grown on coverslips and, where indicated, MCF-7 cells were
transfected as described. Before nuclear staining, the cells were washed
three times with PBS and fixed in 4% paraformaldehyde for 10 min at
room temperature. Coverslips were rinsed three times with PBS and
stained for 10 min with 0.5 
 
m
 
g/ ml propidium iodide and 0.2 mg/ml RNase
A, followed by a final rinse in PBS and mounting. Staining of the mito-
chondria was performed by incubating cells with MitoTracker™ red
CMXRos (20 nM) for 15 min at 37
 
8
 
C. The cells were washed twice in PBS,
fixed for 10 min in 4% paraformaldehyde, and mounted. For immunocy-
tochemistry, the cells were fixed in methanol/acetone (1:1) for 20 min, per-
meabilized using 0.1% Triton in PBS for 30 min, and rinsed twice in PBS.
After blocking in PBS containing 4% BSA for 1 h, the cells were incu-
bated with primary antibody and diluted in 4% BSA for 2–4 h at room
temperature. The cells were rinsed twice with PBS and left for 30 min in
PBS before adding the secondary antibody for 1 h at 37
 
8
 
C. These second-
ary antibodies, anti-mouse or anti-rabbit Alexa 568 and 488 (Molecular
Probes Inc.), respectively, were used at 1:200 dilution. The cells were
washed and, where indicated, nuclei were labeled by staining cells for 20
min with Hoechst 33258 (5 
 
m
 
g/ml) or propidium iodide (0.5 
 
m
 
g/ml) before
mounting onto glass slides using Vectashield
 
®
 
 (Vector Laboratories). Op-
tical sections were taken using an argon-krypton laser and a Leica TCS-
4D confocal imaging system.
 
Electron Microscopy and Immunogold Cytochemistry
 
Nonadherent cells were dislodged by swirling the medium before removal,
and spun down in a swing-out rotor at 3,000 
 
g
 
. The pellets, like the cells re-
 
maining in the plates, were fixed overnight, at 4
 
8
 
C, with 2% glu-
taraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. Adherent cells
were processed in situ or scraped from the plates and spun down to form
pellets. All samples were postfixed with 1% osmium tetroxide/1% potas-
sium ferrocyanide, en bloc stained with 5% uranyl acetate, and embedded
in Taab epoxy resin (Taab Ltd.). Duplicate pellets were fixed with a mix-
ture of 4% formaldehyde, freshly made from paraformaldehyde, and
0.1% glutaraldehyde in Dulbecco’s PBS, pH 7.4, for 1 h at room tempera-
ture. They were rinsed in PBS and embedded in Unicryl resin (Dinsdale
et al., 1999). Ultrathin sections were blocked with normal goat serum, di-
luted 1:50 in PBS containing 1% BSA and 1% Tween 20, for 4 h at room
temperature. Serial sections were incubated, for 18 h at 4
 
8
 
C, with antibod-
ies to 
 
b
 
-actin, tubulin, vimentin, and a range of cytokeratins. These pri-
mary antibodies were all diluted in PBS containing 1% normal goat se-
rum, 1% BSA, and 1% Tween 20 (PBSGAT). In control incubations, the
primary antibodies were replaced with mouse IgG1 or normal rabbit
serum (Dako Ltd). Thorough washing in PBSGAT was followed by incu-
bation, for 18 h at 4
 
8
 
C, in the appropriate goat-derived anti–mouse or
anti–rabbit IgG (British Biocell International Ltd). These secondary anti-
bodies, which had been absorbed against human serum proteins and con-
jugated with 10 nm colloidal gold, were diluted 1:50 in PBSGAT. Sections
incubated with a mixture of the M30 and 3055 antibodies were subse-
quently labeled with a mixture of anti-mouse antibody conjugated with 10
nm gold and anti-rabbit antibody conjugated with 5 nm gold, respectively.
Ultrathin sections were examined unstained or after staining with lead ci-
trate and/or uranyl acetate.
 
Results
 
TRAIL-induced Apoptosis in MCF-7 Cells Results in an 
Early Activation of the Initiator Caspase-8 and Its 
Obligatory Substrate Bid
 
TRAIL induced a time-dependent induction of apoptosis
in MCF-7 cells when assessed, by determining the percent-
age of apoptotic nuclei with 
 
z
 
35% apoptosis detected by
6 h. To determine which caspases were activated and their
order of activation, Western blot analysis was performed.
In untreated MCF-7 cells, caspase-8 was present primarily
as two isoforms of 
 
z
 
55 kD (Fig. 1 A, lane 1), correspond-
ing to caspase-8a and -8b (Scaffidi et al., 1997). Induction
of apoptosis by TRAIL resulted in a time-dependent pro-
cessing of caspase-8 initially to two fragments of 
 
z
 
43 and
41 kD, corresponding to cleavage of the small subunit
from caspase-8a and -8b. This was followed by the appear-
ance of a p18 subunit as a result of cleavage of the death
effector domains from the 43- and 41-kD fragments (Fig. 1
A, lanes 2–7). An increase in the processing of caspase-8
(to yield fragments of 41 and 43 kD) was first observed 30
min after TRAIL treatment. Untreated MCF-7 cells con-
tained the 46-kD proform of caspase-9 (Fig. 1 A, lane 1),
which on induction of apoptosis by TRAIL, was processed
in a time-dependent manner to yield fragments of 37 and
35 kD (Fig. 1 A, lanes 2–7), as a result of cleavage at Asp
315 and Asp 330 (Srinivasula et al., 1998). Caspase-7, a
major effector caspase, was present in MCF-7 cells prima-
rily as its intact 35-kD proform (Fig. 1 A, lane 1). Treat-
ment with TRAIL resulted in a time-dependent process-
ing of caspase-7, which was accompanied by the formation
of the 19-kD catalytically active large subunit (Fig. 1 A,
lanes 2–7). Processing of caspases-7 and -9 was first ob-
served 60–120 min after treatment with TRAIL.
Bid is a specific proximal substrate of caspase-8 in the
CD95 signaling pathway (Li et al., 1998; Luo et al., 1998).
Cleavage of Bid by caspase-8 realizes its potent proapop-
totic activity, which is important for the release of cyto- 
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chrome 
 
c
 
. Therefore, we wished to investigate whether
cleavage of Bid also occurred during TRAIL-induced apop-
tosis. Bid was present in MCF-7 cells as a 26-kD protein,
which, after exposure to TRAIL, was cleaved initially to
yield a major fragment of 15 kD together with a minor
13-kD fragment. This cleavage was first observed at 45
min (Fig. 1 A), which is consistent with an early activation
of caspase-8. Our data demonstrate the sequential activa-
tion of caspase-8 and Bid, followed by activation of
caspases-7 and -9. These results support the hypothesis
that caspase-8 is the apical caspase in TRAIL-induced
apoptosis.
 
Redistribution of Caspases-3, -7, and -8 during
TRAIL-induced Apoptosis in MCF-7 Cells
 
We have previously shown that a redistribution of effector
caspases occurs during CD95-induced apoptosis in vivo
(Chandler et al., 1998). Therefore, we wished to investi-
gate the subcellular distribution of caspases in intact cells
during TRAIL-induced apoptosis. As our polyclonal anti-
bodies to caspases-7 and -8 were unsuitable for immuno-
cytochemistry, we constructed initiator and effector cas-
pases containing green fluorescent protein (GFP) at their
COOH termini (Fig. 1 B). To facilitate the localization of
these GFP-tagged caspases, they were transiently trans-
fected into MCF-7 cells, an adherent cell line. To en-
sure that GFP fusion at the COOH terminus did not af-
fect the activation of caspases, caspase-3-GFP–transfected
cells were analyzed by immunoblotting (Fig. 1 B). As
MCF-7 cells contain no endogenous caspase-3 (Jänicke et
al., 1998), analysis of caspase-3-GFP activation during
TRAIL-induced apoptosis was possible using antibodies
specific to either GFP or caspase-3. In cells transfected
with GFP alone, no significant decrease in GFP protein
 
levels was observed after treatment with TRAIL for 6 h
(Fig. 1 B, top, lanes 1 and 2). Transfection of caspase-3/GFP,
and subsequent exposure to TRAIL, resulted in a time-
dependent processing of caspase-3-GFP to yield a frag-
ment of 37 kD (Fig. 1 B, top, lanes 3–6). This cleavage
product represents the p12 subunit of caspase-3 fused to
GFP, and is the product of cleavage at Asp-175. Western
blot analysis using a caspase-3–specific antibody con-
firmed that the MCF-7 cells used in this study were
caspase-3 null (Fig. 1 B, bottom, lanes 1 and 2), and that
TRAIL-induced apoptosis of cells transfected with cas-
pase-3-GFP was associated with time-dependent process-
ing of intact caspase-3-GFP to fragments of p20, p19, and
p17 (Fig. 1 B, bottom, lanes 3–6). In addition, lysates pre-
pared from cells transfected with caspase-3-GFP exhibited
an increased (3.9 nmol/mg/min) caspase-3–like DEVDase
activity when compared with lysates obtained from control
MCF-7 cells (0.2 nmol/mg/min). Thus, GFP fusion at the
COOH terminus of caspase-3 did not interfere with the
TRAIL-induced processing of this molecule at Asp-9,
Asp-28, or Asp-175 (Fernandes-Alnemri et al., 1996). Sim-
ilarly, GFP fusion at the COOH terminus of caspase-7 did
not affect its activation (data not shown).
Confocal analysis of control MCF-7 cells transfected
with GFP-tagged caspases-3, -7, or -8, demonstrated a sim-
ilar pattern of diffuse cytoplasmic staining for all three
caspases (Fig. 2, C, E, and G). Counterstaining of the nu-
clei in control cells, with propidium iodide, confirmed that
the subcellular distribution of caspases-3, -7, and -8 in
these cells was primarily cytosolic (Fig. 2, C, E, and G).
After treatment with TRAIL for 6 h, MCF-7 cells dis-
played several characteristic features of adherent cells un-
dergoing apoptosis including cell shrinkage and nuclear
condensation (Fig. 2, B, D, F, and H). In MCF-7 cells
transfected with GFP-tagged caspases-3 and -7, a dramatic
Figure 1. Caspase-8 is the
most apical caspase in TRAIL-
induced apoptosis in MCF-7
cells. (A) MCF-7 cells were
incubated for up to 2 h, either
alone or in the presence of re-
combinant TRAIL (1 mg/ml)
and the time course of cleav-
age of the initiator caspases-8
and -9, the effector caspase-7,
and the regulatory molecule
Bid were assessed by Western
blot analysis as described in
Materials and Methods. The
asterisk marks nonspecific
protein bands detected by the
caspase-8 antibody in MCF-7
cells. (B) MCF-7 cells were
transiently transfected with
pEGFP-N1 or caspase-3-GFP
and, 16 h after transfection,
were incubated for up to 6 h
with recombinant TRAIL (1
mg/ml). Cells were analyzed
by immunoblotting using an anti-GFP antibody (top) or an antibody that recognizes the p17 subunit of caspase-3 (bottom). The
caspase-3-GFP structure outlines the boundaries of the two caspase subunits and the NH2-terminal prodomain (Pro). Cleavage to gen-
erate fully processed enzyme occurs at Asp-175, Asp-9, and Asp-28. 
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redistribution of green fluorescence into large spheroidal
inclusions was clearly visible in the cytoplasm of apoptotic
cells (Fig. 2, D and F). Interestingly, in these cells, almost
all of the active effector caspases were redistributed into
the large inclusions, with little active caspase detectable
elsewhere in the cell (Fig. 2, D and F). In contrast, treat-
ment of cells with TRAIL resulted in a redistribution of
active caspase-8 into small punctate inclusions in the cyto-
plasm of apoptotic cells (Fig. 2 H). Treatment of MCF-7
cells with anti-CD95 resulted in similar changes in caspase
Figure 2. TRAIL-induced apoptosis results in
redistribution of caspases-3, -7, and -8. MCF-7
cells were transiently transfected with pEGFP-
N1 (A and B), caspase-3-GFP (C and D),
caspase-7-GFP (E and F), or caspase-8–GFP (G
and H). At 24 h after transfection, cells were in-
cubated either alone (A, C, E, and G) or in the
presence of recombinant TRAIL (1 mg/ml; B, D,
F, and H) for 6 h, stained with propidium iodide
to label DNA, and analyzed by confocal micros-
copy. GFP exhibits an even cellular distribution:
orange/yellow fluorescence being evident in the
nucleus because of colocalization of GFP and
propidium iodide. Note the redistribution of
caspases-3 and -7-GFP into large spheroidal in-
clusions in apoptotic MCF-7 cells, whereas
caspase-8 exhibits a discrete punctate distribu-
tion in cells exhibiting altered nuclear morphol-
ogy. Bar, 10 mm. 
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distribution (data not shown). Thus, after TRAIL or
CD95-induced apoptosis, a marked redistribution of cas-
pases was observed, which differed between the effector
caspases-3 and -7 and the initiator caspase-8.
 
Neither Mitotracker nor Calnexin Colocalize with 
GFP-tagged Caspases-3, -7, or -8
 
The TRAIL-induced redistribution of GFP-tagged cas-
pases-3, -7, and -8 into intracytoplasmic spheroidal inclu-
sions led us to investigate the nature of these structures.
Using the selective dye MitoTracker red, mitochondria
were clearly visible by confocal microscopy in control
MCF-7 cells as discrete punctate structures throughout the
cytoplasm, particularly in the perinuclear region (Fig. 3
A). No colocalization of caspase-3 with the mitochondria
of MCF-7 cells was apparent when this distribution was
compared with that of the GFP-tagged caspase-3. Treat-
ment of caspase-3–transfected cells with TRAIL, followed
by costaining with MitoTracker red, confirmed the subcel-
lular redistribution of GFP-tagged caspase-3 into large
spheroidal inclusions, and revealed that these structures
were distinct from the mitochondria of apoptotic cells
(Fig. 3 B). Similarly, no colocalization of calnexin, an ER
transmembrane protein, was observed with either GFP-
tagged caspase-3 in control MCF-7 cells (Fig. 3 D) or with
the caspase-associated spheroidal inclusions induced by
TRAIL (Fig. 3 E). Induction of apoptosis by TRAIL in
caspase-7–transfected MCF-7 cells again resulted in the
formation of large spheroidal inclusions that did not colo-
calize with mitochondria or the ER (Fig. 3, C and F). Simi-
larly, actin, a major component of the cytoskeleton, did
not colocalize with caspase-3 or -7 in control MCF-7 cells
or after TRAIL treatment (data not shown). Furthermore,
the small punctate inclusions detected in TRAIL-induced
apoptotic MCF-7 cells transfected with GFP-tagged cas-
pase-8 did not colocalize with mitochondria, ER, or the ac-
tin cytoskeleton (data not shown).
 
TRAIL Induces Spheroidal Inclusions in the Cytoplasm 
of Untransfected and Transfected MCF-7 Cells
 
The identity of the GFP-tagged caspase-3 and caspase-
7–associated spheroidal inclusions in TRAIL-treated
MCF-7 cells was further examined at the ultrastructural
level. Initially, we confirmed that these inclusions were
also formed in untransfected cells. Sections through un-
treated cultures showed a predominance of large cells, up
Figure 3. TRAIL-induced
apoptosis results in colocal-
ization of active transfected
effector caspases and cleaved
cytokeratin 18 in MCF-7
cells. MCF-7 cells were tran-
siently transfected with
caspase-3-GFP (A, B, D, and
E) or caspase-7-GFP (C and
F) and, 24 h later, the cells
were treated with recombi-
nant TRAIL (1 mg/ml; B, C,
E and F) for 6 h. Cells were
stained either with Mito-
Tracker red (A–C) or by in-
direct immunofluorescence
for calnexin (D–F). (G–I)
MCF-7 cells were transfected
with caspase-3-GFP and, 16 h
later, were treated with re-
combinant TRAIL (1 mg/ml)
for 6 h. (G) Confocal analysis
demonstrates the redistribu-
tion of caspase-3-GFP into
large spheroidal inclusions in
apoptotic cells. (H) Indirect
immunofluorescence with
antibody M30, which recog-
nizes a neo-epitope in K18 at
DALD397¯S, confirmed that
the caspase-3-GFP–contain-
ing spheroidal inclusions also
contained cleaved cytokera-
tin 18. I is an overlay of im-
ages G and H, demonstrating
the colocalization of caspase-
3-GFP and cleaved cytokera-
tin 18 in apoptotic cells. Bar,
10 mm. 
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to 15 
 
m
 
m in diameter, which were interconnected by tight
junctions (Fig. 4 A). The electron lucent cytoplasm con-
tained a diffuse network of microfilaments and intermedi-
ate filaments. The nuclear profiles were regular and char-
acterized by a thin rim of heterochromatin lining the inner
membrane of the nuclear envelope. Treatment of untrans-
fected MCF-7 cells with TRAIL (Fig. 4, B and C) or anti-
CD95 (data not shown) resulted in the formation of apop-
totic cells with a cytoplasm, which was particularly electron
dense even in the absence of fixation with osmium tetrox-
ide. The apoptotic MCF-7 cells were also characterized by
nuclei with clumps of moderately condensed perinuclear
chromatin that extended into the nucleoplasm, ultra-
condensed mitochondria, dilation of the ER, and distinct
sheaves of filaments (Fig. 4 B). In some apoptotic cells,
small cytoplasmic inclusions (
 
,
 
1 
 
m
 
m diam) of a fine amor-
phous material were also observed (Table I). These inclu-
sions (Fig. 4, B and C) were sharply demarcated from the
surrounding cytoplasm but, like the actin-rich structures
reported in the cytoplasm of apoptotic monocytes (Dins-
dale et al., 1999), they were devoid of any limiting mem-
brane. The nuclear changes observed contrast with the
classical apoptotic characteristic of sharply delineated
dense chromatin crescents abutting the inner nuclear
membrane. This intermediate stage of chromatin conden-
sation observed in apoptotic MCF-7 cells, is almost cer-
tainly the result of these cells being caspase-3 null (F. Li et
al., 1997; Jänicke et al., 1998).
Ultrastructural analysis of MCF-7 cells transfected with
either Lipofectamine or GFP alone revealed the majority
of these cells to be indistinguishable from control cells
(data not shown). Treatment of untransfected cells with
TRAIL for 7 h, resulted in the induction of apoptosis and
the presence of keratin-containing inclusions in 12% of
nonadherent cells (Table I). When cells transfected with
GFP-tagged caspases-3
 
 
 
or -7 were exposed to TRAIL,
there was a marked increase in apoptotic cells with a strik-
ing presence of many more and larger cytoplasmic inclu-
sions (Fig. 4 D) associated with loss of cytoplasmic fila-
ments. These larger inclusions were spheroidal, up to 5 
 
m
 
m
in diameter, and apparently formed by fusion of numerous
smaller inclusions (data not shown). Transfected cells with
large inclusions showed more pronounced nuclear changes
than cells treated with TRAIL alone. These nuclear
changes usually included disruption or loss of the nuclear
envelope and dispersal of the nucleolus (Fig. 4 D). Similar
nuclear changes and large cytoplasmic spheroidal inclu-
sions were observed after anti-CD95 treatment of cells
transfected with GFP-tagged caspase-3 or -7 (data not
shown). In contrast, cells treated with TRAIL or anti-
CD95 after transfection with caspase-8 did not undergo ei-
ther of these changes. However, these cells contained the
small cytoplasmic inclusions observed in nontransfected
cells that had been treated with these agents (data not
shown). Thus, transfection with GFP-tagged caspases-3 or
-7, but not caspase-8, followed by treatment with TRAIL
or anti-CD95 resulted in an exaggerated apoptotic pheno-
type compared with cells treated with TRAIL or anti-
CD95 alone. This exaggerated phenotype was character-
ized by pronounced nuclear disruption and the formation
of the large spheroidal inclusions (Fig. 4, compare B and
D), which corresponded in size and distribution to those
observed by confocal microscopy (Figs. 2 and 3).
 
Cytokeratins 8, 18, and 19 Are Redistributed into the 
Large Spheroidal Inclusions
 
TRAIL-induced formation of large spheroidal inclusions
in cells transfected with effector caspases was accompa-
nied by the loss of detectable cytofilaments (Fig. 4 D);
therefore, the subcellular distribution of cytofilament pro-
teins in apoptotic cells was investigated. Immunogold la-
beling of ultrathin sections indicated that the spheroidal
inclusions contained cytokeratins but not 
 
b
 
-actin, tubulin,
or vimentin. A specific mAb to K18 produced intense, spe-
cific immunogold labeling of the spheroidal inclusions of
cells transfected with GFP-tagged caspase-3 or -7 and
treated with TRAIL (Fig. 5 A and data not shown). Inter-
mediate filament disorganization and reorganization oc-
curs during mitosis and is associated with phosphorylation,
primarily on serine 53 of K18 (Ku and Omary, 1994). Im-
munogold labeling with antibody 3055, which specifically
recognizes the K18 phosphorylated on serine 53 (P-K18;
Liao et al., 1995), clearly demonstrated its accumulation in
the spheroidal inclusions (Fig. 5 D). mAbs specific to the
two other major cytokeratins present in MCF-7 cells,
namely K8 and 19 (Moll et al., 1982), also labeled these
spheroidal inclusions, whereas antibodies to K13, 15, and
16 did not (data not shown). There were no obvious inclu-
sions in untreated MCF-7 cells, but the filament network
was labeled by K8, 18, and 19 (Fig. 5 B, inset, and data not
shown). In nontransfected TRAIL-treated cells, these an-
tibodies labeled the distinctive sheaves of filaments (Fig. 5
B) and the small inclusions, which characterized these
cells. In contrast, antibody M30, which specifically recog-
nizes a caspase cleavage site within K18, did not label ei-
ther the filament network or the sheaves of filaments (data
not shown), but it did label the spheroidal inclusions (Fig.
5 C). M30 recognizes a neo-epitope, DALD
 
397
 
, in the
COOH terminus of K18 exposed early during apoptosis
(Leers et al., 1999). Furthermore, colabeling of the sphe-
roidal inclusions with antibody 3055 (5 nm immunogold)
and the M30 antibody (10 nm immunogold) was also ob-
served (Fig. 5 D). Thus, the distinctive large spheroidal in-
clusions in apoptotic MCF-7 cells contained K8, 18, and 19
as well as P-K18, and resulted from redistribution and
cleavage of the intermediate filaments.
 
Table I. TRAIL Induces Cytokeratin-containing Inclusions in 
Epithelial Cells
 
Cell line
Percentage of cells containing inclusions
Control TRAIL
Adherent cells Adherent cells Nonadherent cells
 
MCF-7 0 4 (0.7)* 12 (0.8)
A549 0 6 (1.5) 93 (6.0)
HBL100 0
 
,
 
1 (0.5) 64 (0.8)
 
Cells were treated with TRAIL (1 
 
m
 
g/ml) for 7 h and nonadherent cells were centri-
fuged. Insufficient nonadherent cells were obtained in control cultures to yield a cell
pellet. Both adherent and nonadherent cells were fixed and labelled with immunogold
using a mixture of mAbs to cytokeratins 8, 18, and 19. The percentage of cells con-
taining cytokeratin inclusions was determined. Intermediate filaments were positively
labelled in all untreated cells.
*The number in parentheses indicates the maximum diameter (expressed in 
 
m
 
m) of
the cytokeratin-containing inclusions. 
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TRAIL-induced Colocalization of Active Effector 
Caspases and Cleaved Cytokeratin 18
 
We wished to determine whether the GFP-containing
spheroidal inclusions observed by confocal microscopy in
TRAIL-induced MCF-7 cells transfected with GFP-tagged
caspases-3 and -7 (Fig. 2, D and F) were associated with
cleaved cytokeratins. Using the M30 antibody, we per-
formed immunocytochemistry on caspase-3-GFP–trans-
fected MCF-7 cells that had been exposed to TRAIL for
6 h. Immunolabeling for cleaved K18 was only present in
apoptotic cells and was predominantly localized in discrete
cytoplasmic structures and on the periphery of large sphe-
roidal inclusions (Fig. 3 H), which resembled those inclu-
sions previously shown to contain caspase-3 or -7 in trans-
fected cells (Figs. 2, D and F, and 3 G). As antibody M30
only recognizes cleavage of K18 at DALD
 
397
 
¯
 
S, we cannot
exclude the possibility that cleavage at VEVD
 
238
 
¯
 
A has
also occurred either before or in parallel with sequestra-
tion of cleaved K18 into spheroidal inclusions after
TRAIL-induced apoptosis. Preferential immunolabeling
Figure 4. Ultrastructural
changes in untransfected and
caspase-3–transfected MCF-7
cells after treatment with
TRAIL. (A) The electron lu-
cent cytoplasm of an un-
treated cell contains a diffuse
network of filaments. A few
short microvilli are present
on the apical membranes and
small osmiophilic granules
(black arrows) are evident in
the underlying cytoplasm.
The nucleus (N) is regular
and characterized by a thin
rim of heterochromatin. (B)
An untransfected cell, 6 h af-
ter treatment with TRAIL,
showing a scalloped nucleus
(N) containing clumps of
moderately condensed chro-
matin that extend to the nu-
cleolus. The characteristic
electron dense cytoplasm of
this cell contains ultracon-
densed mitochondria (white
arrows), distinct sheaves of
filaments (double white ar-
rows), and small inclusions of
a fine amorphous material
(outlined area). (C, detail
from area outlined in B) The
cytoplasmic inclusions (aster-
isk) are devoid of any limiting
membrane, but some sheaves
of filaments (double white ar-
rows) are associated with
their periphery. (D) A cell
from a culture transfected
with caspase-3, and treated
with TRAIL for 6 h, showing
disruption of the nuclear en-
velope (white arrowheads)
and dispersal of the nucleo-
lus. The cytoplasm contains
numerous ultracondensed
mitochondria (white arrows)
and two large spheroidal in-
clusions (asterisk) that con-
sist of a fine amorphous ma-
terial. Bars, 1 mm. 
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of the periphery of inclusions by antibody M30 was almost
certainly the result of their impermeability to antibodies as
immunogold studies, using ultrathin sections, showed uni-
form labeling throughout the inclusions (Fig. 5 D). De-
spite these difficulties with antibody accessibility, it was
evident that GFP-tagged caspase-3 and cleaved K18 were
colocalized in large spheroidal inclusions present in MCF-7
cells after exposure to TRAIL (Fig. 3 I). Similar results
were obtained when HeLa cells, transfected with caspase-
3- or -7-GFP and exposed to TRAIL, were colabeled with
antibody M30 (data not shown). Thus, activated caspases-3
and -7 are associated with cleaved K18 in apoptotic MCF-7
cells, further supporting the hypothesis that effector cas-
pases are primarily responsible for the ordered disman-
tling of the filament structure in epithelial cells during
apoptosis.
Figure 5. Ultrastructural lo-
calization of cytokeratins in
control, caspase-3, and
caspase-7–transfected MCF-7
cells after treatment with
TRAIL. (A) The cytoplasm
of a cell transfected with
caspase-3, and exposed to
TRAIL for 6 h, is largely de-
void of labeling for K18, but
the label is concentrated over
large (asterisks) and small
spheroidal inclusions. Rem-
nants of the dense, fibrillar
component (black arrow-
heads) are evident alongside
the enlarged granular com-
ponent (curved black arrow)
of the nucleolus. The inset is
a threefold magnification of
the area outlined. (B) In a
nontransfected cell, exposed
to TRAIL for 6 h, K18 is lo-
calized in sheaves (double
white arrows) present
throughout the cytoplasm.
The inset shows the diffuse
distribution of cytokeratin
18–labeled intermediate fila-
ments in control cells. (C)
The cytoplasm of a cell trans-
fected with caspase-7, and
exposed to TRAIL for 6 h,
contains a large spheroidal
cytoplasmic inclusion (aster-
isk), together with two
smaller inclusions (curved
white arrows) which are la-
beled with 10 nm immu-
nogold after incubation with
the M30 antibody, which is
specific to the cleaved form
of K18. The rest of the cell,
including a remnant of the
nucleolar dense fibrillar com-
ponent (black arrowhead) is
devoid of label. The inset is a
threefold magnification of
the area outlined. (D) The
cytoplasm of a cell trans-
fected with caspase-7 and ex-
posed to TRAIL for 6 h. La-
beling by both the M30 antibody (10 nm immunogold) and the 3055 antibody, which is specific to the phosphorylated form of this
cytokeratin (5 nm immunogold), is evident over a large spheroidal inclusion (asterisk). The inset is a threefold magnification of the area
outlined. Bars, 1 mm. 
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Effector Caspases Induce Cleavage of Cytokeratins 8, 
18, and 19 during TRAIL-induced Apoptosis
 
To determine the integrity and phosphorylation state of
the cytokeratin proteins during apoptosis, MCF-7 cells
were transfected with caspase-7-GFP, treated with TRAIL
for 5 h, and sorted into two populations containing either
untransfected cells or cells transfected with caspase-7-GFP
(Fig. 6 A). Control MCF-7 cells contained K8, 18, and
19 as intact proteins of 52, 48, and 40 kD, respectively.
Treatment of untransfected or caspase-7-GFP–transfected
MCF-7 cells with TRAIL resulted in cleavage of K19 to
yield a fragment of 
 
z
 
38 kD and cleavage of K8 to yield a
fragment of 
 
z
 
46 kD and possibly one of 
 
z
 
48 kD (Fig. 6
A). Cleavage of both K8 and K19 has been reported dur-
ing radiation-induced apoptosis of breast tumor cells
(Prasad et al., 1998). Although K8 cleavage also occurs in
the nonsmall-cell lung cancer cell line, MRC65 (van Enge-
land et al., 1997), its cleavage may be a cell type–specific
phenomenon as it is relatively spared during apoptosis of
several other epithelial cell types (Caulin et al., 1997; Ku
et al., 1997). In the MCF-7 cells treated with TRAIL for
5 h, K18 was cleaved to yield a fragment of 
 
z
 
26 kD but, in
the cells transfected with caspase-7-GFP, an additional
cleavage product of 
 
z
 
19 kD was also detected (Fig. 6, A
lane 3). This result implicated effector caspases in the deg-
radation of the cytoskeleton in agreement with previous
work that identified a specific caspase cleavage site in K18
during drug and UV-induced apoptosis (Caulin et al.,
1997). Using recombinant caspases as well as various mu-
tants, these authors demonstrated that caspase-3, -6, or -7
 
could cleave K18 at VEVD
 
238
 
¯
 
A, located within the non-
 
a
 
-helical L1-2 linker region, yielding a 26-kD NH
 
2
 
-termi-
nal and a 22-kD COOH-terminal fragment. A caspase-3 or
-7 COOH-terminal cleavage site, which results in cleavage
of intact K18 to a 45-kD fragment or further processing of
the 22-kD fragment to an 
 
z
 
19-kD fragment, was also
noted but not identified (Caulin et al., 1997).
To further investigate the role of caspases in TRAIL-
induced cleavage of cytokeratins, we exposed either con-
trol or transfected MCF-7 cells to TRAIL in the presence
of two caspase inhibitors (Fig. 6 B). z-VAD.FMK is a
broad spectrum caspase inhibitor, whereas YVAD.CMK
is reported to be more specific for caspases-1 and -6 (La-
zebnik et al., 1995; MacFarlane et al., 1997b). Treatment
of control MCF-7 cells, or cells transfected with GFP
alone, with TRAIL for 7 h resulted in cleavage of K18 to
yield four immunoreactive products of 
 
z
 
45, 26, 22, and 19
kD (Fig. 6 B, lanes 2 and 4). In cells transfected with
caspase-3-GFP either alone or treated with TRAIL, cleav-
age of K18 predominantly yielded the 19-kD product with
small amounts of the other fragments (Fig. 6 B, lanes 5 and
6). The 26-kD but not the 22- or 19-kD fragments was also
detected by the P-K18–specific antibody, 3055 (Fig. 6 B),
supporting the suggestion that the 26- and 22-kD products
are the NH
 
2
 
 and COOH terminally derived fragments, re-
spectively, resulting from cleavage at VEVD
 
238
 
¯
 
A (Fig. 6
C). The M30 antibody, which recognizes the neo-epitope
DALD
 
¯
 
S, labeled the 19-kD but not the 26- or 22-kD
fragments (data not shown), suggesting that the 19-kD
product was derived from further cleavage of the 
 
z
 
22-
kD product at DALD
 
397
 
¯
 
S (Fig. 6 C). Thus, in the absence
Figure 6. Cytokeratins 8, 18, and 19 together
with P-K18 are cleaved by effector caspases dur-
ing TRAIL-induced apoptosis. (A) MCF-7 cells
were transiently transfected with caspase-7-GFP
and, 24 h later, were incubated with recombinant
TRAIL (1 mg/ml) for a further 5 h. Cells were
sorted by flow cytometry into two populations of
cells exposed to TRAIL: untransfected cells and
those expressing caspase-7-GFP. Control cells
contained primarily the intact forms of all three
cytokeratins (lane 1). In cells treated with
TRAIL, processing of K8, 18, and 19 was de-
tected, with K18 being more extensively pro-
cessed in cells expressing caspase-7-GFP (lanes 2
and 3, respectively). The asterisks mark nonspe-
cific bands of z49 and 47 kD detected by the
K8 and K18 antibodies, respectively. (B) z-VAD.
FMK blocks the cleavage of cytokeratins. MCF-7
cells were transiently transfected with pEGFP-
N1 or caspase-3-GFP either in the absence or
presence of YVAD.CMK (10–50 mM) or z-VAD.
FMK (10–50 mM). Control cells, or cells trans-
fected with GFP alone or caspase-3-GFP, were
treated with recombinant TRAIL (1 mg/ml) for
7 h and analyzed by Western blot analysis. Ex-
tensive cleavage of K18 and P-K18, induced by
transfection of caspase-3-GFP and a 7-h exposure to TRAIL, was blocked by z-VAD.FMK but only partially inhibited by
YVAD.CMK. (C) A schematic representation of the potential fragments resulting from cleavage of K18 by effector caspases. The K18
antibody, CY90, detects intact K18 together with fragments of 45, 26, 22, and 19 kD. In contrast, antibody 3055, which is specific for K18
phosphorylated on serine 53, detects only K18 and a 26-kD fragment generated by cleavage at VEVD238¯S. 
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of caspase-3, K18 was preferentially cleaved to a 26-kD
fragment (Fig. 6 B, lanes 2 and 4), but in the presence of
either caspase-3 (Fig. 6 B, lane 6) or caspase-7 (Fig. 6 A,
lane 3), the additional 19-kD product was also observed.
Pretreatment of cells with z-VAD.FMK (10–50 
 
m
 
M) inhib-
ited apoptosis and cleavage of both K18 and P-K18 in a
concentration-dependent manner (Fig. 6 B, lanes 7–9). Al-
most complete inhibition was observed at the highest con-
centration (Fig. 6 B, lanes 7–9), which is consistent with
the ability of z-VAD.FMK to inhibit the proteolytic activ-
ity of all known caspases (Garcia-Calvo et al., 1998).
YVAD.CMK (10–50 
 
m
 
M), which caused only a slight inhi-
bition of apoptosis (Fig. 6 B), did not markedly inhibit
 
the processing of K18 or P-K18 (Fig. 6 B, lanes 10–12).
In contrast, in untransfected MCF-7 cells exposed to
TRAIL, YVAD.CMK (25 
 
m
 
M) completely inhibited for-
mation of the 26- and 19-kD cleavage products of K18
(data not shown), which is consistent with previous re-
ports that cleavage of K18 at VEVD
 
¯
 
A, is primarily me-
diated by caspase-6. Thus, the inability of YVAD.CMK
to significantly inhibit K18 cleavage in the presence of
exogenously transfected caspase-3 or -7 (Fig. 6 B) is con-
sistent with cleavage of K18 occurring, in this instance, at
both the caspase-3 and/or -7 preferred site, DALD
 
¯
 
S
and the VEVD
 
¯
 
A site normally preferred by caspase-6
(Fig. 6 C).
Figure 7. TRAIL induces
spheroidal inclusions in
HBL100 cells. (A) Untreated
adherent HBL100 cells dis-
play a regular nucleus (N) and
are devoid of cytoplasmic in-
clusions. (B) After exposure
to TRAIL for 7 h, detached
cells show characteristic apop-
totic nuclear morphology and
small spheroidal cytoplasmic
inclusions (black arrowheads).
(C and D) These inclusions
(black arrowheads) contain
cleaved K18 as shown by im-
munogold labeling with anti-
body M30. The inset in C is
shown at a higher magnifica-
tion in D. Bars, 1 mm.The Journal of Cell Biology, Volume 148, 2000 1250
Redistribution of Cleaved Cytokeratins into Spheroidal 
Inclusions Is a Characteristic Feature of Epithelial 
Cells Undergoing Apoptosis
We wished to determine whether the spheroidal inclusions
observed in transfected or untransfected MCF-7 cells ex-
posed to TRAIL (Figs. 4 and 5) were also evident in other
epithelial cells undergoing apoptosis. HBL100, breast epi-
thelial cells, and A549, type II lung cells, were exposed to
TRAIL and examined by ultrastructural immunocyto-
chemistry. Sections through untreated cultures of HBL100
(Fig. 7 A) and A549 (Fig. 8 A) cells showed a predomi-
nance of large adherent cells with regular nuclear profiles.
Treatment of these cells with TRAIL resulted in an in-
creased incidence of apoptotic cells, characterized by de-
tachment, rounding-up and chromatin margination (Figs.
7 B and 8 B). The hypercondensed mitochondria observed
in apoptotic MCF-7 cells (Fig. 4) and apoptotic THP.1
cells (Dinsdale et al., 1999) were not observed in either
HBL100 or A549 cells, suggesting that these changes are
only associated with the apoptotic phenotype of certain
cells.
Apoptotic HBL100 cells were also characterized by the
presence of small cytoplasmic inclusions (,1 mm diam)
with an indistinct outline. These inclusions were labeled by
antibodies to both intact (Table I) and cleaved K18 (Fig. 7,
Figure 8.  TRAIL induces
spheroidal inclusions in A549
cells. (A) Untreated adher-
ent A549 cells display a regu-
lar nucleus (N) and are devoid
of cytoplasmic inclusions. (B)
After exposure to TRAIL
for 3 h, many detached cells
display a characteristic apop-
totic nuclear morphology and
contain a range of spheroidal
cytoplasmic inclusions (black
arrowheads). (C) These inclu-
sions contain K18 as shown
by immunogold labeling. For
clarity, only one inclusion/
cell is marked (black arrow-
heads). (D) These inclusions
(black arrowheads) also con-
tain cleaved K18 as shown by
immunogold labeling with
antibody M30. Bars: (A, B,
and D) 1 mm; (C) 10 mm.MacFarlane et al. Caspases and Cytokeratins Colocalize in Apoptosis 1251
C and D). In A549 cells exposed to TRAIL, many more
and larger cytoplasmic inclusions were observed, and
these were also labeled by both antibodies (Table I and
Fig. 8, C and D). Thus, redistribution and cleavage of the
cytokeratin network into cytoplasmic inclusions is a char-
acteristic feature of a number of epithelial cell types un-
dergoing apoptosis.
Trail-induced Colocalization of Active Endogenous 
Caspase-3 with Cleaved Cytokeratin 18 in Apoptotic 
Epithelial Cells
The recently characterized M30 antibody recognizes
cleaved K18 in apoptotic cells, but does not recognize un-
cleaved K18 in viable or necrotic cells (Leers et al., 1999).
In both untransfected MCF-7 and HBL100 cells exposed
to TRAIL, M30 immunoreactivity was present only in apop-
totic cells and localized in discrete cytoplasmic inclusions
(Fig. 9, A and B). Similarly, the CM1 antibody recognizes
only the p18 subunit but not the zymogen precursor of
caspase-3 (Srinivasan et al., 1998). CM1 immunoreactivity
was observed only in TRAIL-induced apoptotic HBL100
cells but not in nonapoptotic cells (Fig. 9 C). These studies
confirmed the use of both these antibodies for specifically
labeling apoptotic cells. Interestingly, both M30 (Fig. 9, A,
B, D, and G) and CM1 (Fig. 9, C, E, and H) immunolabel-
ing exhibited a discrete punctate cytoplasmic distribution
in apoptotic cells. Furthermore, when apoptotic cells were
colabeled with CM1 and M30 antibodies, the majority of
active caspase-3 colocalized with the cytokeratin-contain-
ing inclusions (Fig. 9, D–I). These results demonstrated
the redistribution and colocalization of both cleaved K18
and active endogenous caspase-3 into small cytoplasmic
inclusions in both HBL100 and A549 cells undergoing
apoptosis.
Discussion
TRAIL Initiates a Caspase Cascade with Caspase-8 at 
the Apex
Our demonstration of an early cleavage of caspase-8 and
Bid, before activation of caspases-3 and -7, in MCF-7 cells
(Fig. 1), strongly supports the hypothesis that caspase-8 is
the most apical caspase in TRAIL-induced apoptosis. Ac-
tivation of caspases-8 and -3 also has been observed in
melanoma cells exposed to TRAIL (Griffith et al., 1998).
Activated caspase-8 may either directly activate effector
caspases or, via cleavage of Bid lead to the involvement of
mitochondria, indirect activation of caspase-9, and down-
stream effector caspases. Cleavage of Bid, a caspase-8 sub-
strate, only previously has been reported in CD95 and TNF-
a–induced apoptosis (Li et al., 1998). However, our data
Figure 9. Active endogenous
caspase-3 colocalizes with
cleaved cytokeratin 18 in
apoptotic epithelial cells.
MCF-7 (A), HBL100 (B–F),
and A549 (G–I) cells were
treated with recombinant
TRAIL (1 mg/ml) for 5 h, la-
beled with the appropriate
antibody, and stained with
propidium iodide (A–C) or
Hoechst 33258 (F and I) to la-
bel DNA. Indirect immuno-
fluorescence with antibody
M30, confirmed the TRAIL-
induced formation of sphe-
roidal inclusions containing
cleaved K18 specifically in
apoptotic MCF-7 (A),
HBL100 (B and D), and
A549 cells (G). Indirect im-
munofluorescence, with anti-
body CM1, demonstrated
that active caspase-3 was dis-
tributed in spheroidal inclu-
sions specifically in apoptotic
HBL100 (C and E) and A549
(H) cells. F is an overlay of
images D and E, and I is an
overlay of images G and H,
demonstrating that the ma-
jority of active caspase-3
colocalizes with cleaved K18
in apoptotic HBL100 and
A549 cells, respectively. Bar,
10 mm.The Journal of Cell Biology, Volume 148, 2000 1252
now demonstrate the participation of Bid in TRAIL-
induced apoptosis. Recent studies using Bid-deficient
mice have confirmed that Bid is a critical substrate for in
vivo signaling by death receptor agonists, thereby mediat-
ing a mitochondrial amplification loop that is essential for
apoptosis in selected cells (Yin et al., 1999).
After TRAIL-induced apoptosis, the initiator caspase-8
redistributed within the cytosol into discrete punctate
structures (Fig. 2), whereas the effector caspases-3 and
-7 redistributed into large spheroidal inclusions (Figs. 2
and 3). These differences between initiator and effector
caspases further emphasize their fundamentally different
roles in receptor-mediated apoptosis in epithelial cells. In
mouse liver, caspases-3 and -7 are initially cytosolic but,
after CD95-induced apoptosis, show a differential subcel-
lular redistribution (Chandler et al., 1998). The proform of
caspase-3 also has been found primarily in the cytosol to-
gether with small amounts in the mitochondria of several
cell types from rat and human tissues (Mancini et al., 1998;
Samali et al., 1998; Zhivotovsky et al., 1999). However, in
the present study, no colocalization of caspase-3-GFP with
the mitochondria of MCF-7 cells was observed (Fig. 3),
which is in agreement with the finding that the ratio of cy-
tosolic to mitochondrial procaspase-3 varies between dif-
ferent tissues (Samali et al., 1998).
Effector Caspases Promote an Exaggerated
Apoptotic Phenotype
MCF-7 cells are caspase-3 null (F. Li et al., 1997; Jänicke
et al., 1998) and, therefore, provide a good model to dis-
sect the apoptotic pathways for which caspase-3 activation
is necessary. Apoptosis in most cell types is not solely de-
pendent on caspase-3, as mice with a homozygous deletion
in the CASP-3 gene only exhibit hyperplasia and signifi-
cant abnormalities in the brain (Kuida et al., 1996; Woo
et al., 1998). Based on studies using caspase-3–null cells, it
has been proposed that caspase-3 activity is required for
DNA fragmentation and membrane blebbing (Jänicke et al.,
1998; Zheng et al., 1998), but is not essential for induction
of apoptosis by either CD95 or TNF (F. Li et al., 1997). In
the current study, the intermediate stage of chromatin
condensation observed in MCF-7 cells exposed to TRAIL
(Fig. 4) can be attributed to a partial fragmentation of
DNA into kilobase pair fragments in the absence of DNA
ladders (Brown et al., 1993). Overexpression of caspase-3
or -7, but not caspase-8, in cells exposed to TRAIL re-
sulted in a more exaggerated apoptotic phenotype with
larger cytokeratin-containing cytoplasmic inclusions and
more pronounced nuclear changes (Figs. 4 and 5). These
results are consistent with cleavage by effector, but not ini-
tiator, caspases of intracellular substrates, such as DFF
(Liu et al., 1997) and cytokeratins, with appropriate motifs
(e.g., DxxD). This further emphasizes the marked differ-
ences between initiator and effector caspases.
TRAIL Induces the Redistribution of Effector Caspases 
into Cytokeratin-associated Spheroidal Inclusions
Cytokeratins comprise the major intermediate filaments in
the cytoplasm of epithelial cells and help to maintain cellu-
lar integrity. Disintegration of these filaments, resulting in
the concentration of cytokeratins within cytoplasmic inclu-
sions, has been reported in vivo in the Mallory bodies of
injured hepatocytes and also in vitro in mitotic epithelial
cells (Franke et al., 1982). Similar inclusions are observed
in adenovirus-infected HeLa cells after cleavage of K18 by
the viral L3 proteinase (Chen et al., 1993). The signifi-
cance of cytokeratin reorganization during apoptosis only
recently has been examined (van Engeland et al., 1997).
The redistribution of cytokeratins into granular structures
enriched for phosphorylated K18 has been reported in
apoptotic cells (Caulin et al., 1997; Ku et al., 1997). Prima-
rily based on studies with recombinant proteins, this redis-
tribution has been proposed to be dependent on cleavage
of type I keratins by effector caspases. Interestingly, phos-
phorylation of K18 at serine 53 does not render K18 a bet-
ter substrate for effector caspases (Caulin et al., 1997; Ku
et al., 1997).
Our biochemical and ultrastructural data provide new
insight on the fate of cytokeratins during apoptosis. On ex-
posure to TRAIL, the cytokeratin bundles characteristic
of control cells (Fig. 5 B, inset) reorganized into filament
sheaves found either free in the cytoplasm or associated
with the periphery of small inclusions containing K8, -18,
and -19 (Figs. 4, B and C, and 5 B). Cytokeratin disassem-
bly was primarily mediated by effector caspases, as these
inclusions were larger and more pronounced in MCF-7
cells in the presence of exogenously expressed caspases-3
or -7. Both the inclusions and the filament sheaves con-
tained the phosphorylated form of K18, whereas coimmu-
nogold labeling with the M30 antibody demonstrated the
presence of cleaved K18 only in the spheroidal inclusions
(Fig. 5). These data are compatible with initial phosphory-
lation of K18 and the formation of filament sheaves, fol-
lowed by cleavage of K18 at DALD397¯S, which results in
the transformation of these sheaves into inclusions. How-
ever, we cannot exclude the possibility that the filament
sheaves may contain K18 cleaved at other sites, such as
VEVD238¯A, which would not be recognized by the M30
antibody.
Cytokeratin-associated Spheroidal Inclusions Are a 
Characteristic Feature of Epithelial Cell Apoptosis
Particularly striking was the finding of spheroidal inclu-
sions in TRAIL-treated epithelial cells. While initially ob-
served in MCF-7 cells transfected with caspases-3 or -7,
they were subsequently observed in a variety of untrans-
fected TRAIL-treated epithelial cells from the breast
(MCF-7 and HBL100), lung (A549), and cervix (HeLa;
Figs. 4, 7, and 8, and data not shown). These inclusions
contained cleaved K18, which, in both A549 and HBL100
cells, colocalized with active endogenous caspase-3 (Fig.
9). Interestingly, the inclusions were more prevalent in un-
transfected HBL100 and A549 than in MCF-7 cells most
probably because the A549 and HBL100 cells possess suf-
ficient caspase-3 to cleave cytokeratins and form cytoplas-
mic inclusions. The formation of such inclusions appears
to be a general feature of TRAIL-induced apoptosis of ep-
ithelial cells.
These observations raise the question as to why such in-
clusions are formed and why active effector caspases are
sequestered within them. Active caspases may be required
to ensure the ordered dismantling of the intermediate fila-MacFarlane et al. Caspases and Cytokeratins Colocalize in Apoptosis 1253
ment network in epithelial cells undergoing apoptosis. Ef-
fector caspases cleave several other cytoskeletal proteins
including nuclear lamins, fodrin, and actin together with
the cytoskeletal regulators Gas2 and gelsolin (Thornberry
and Lazebnik, 1998); thus, reflecting the requirement for
disassembly of the cytoskeleton during the execution
phase of apoptosis. Alternatively, the sequestration and
subsequent degradation of active effector caspases may
prevent their escape from the cell and, therefore, their
ability to damage healthy neighboring cells. This latter
suggestion is compatible with the observation that apopto-
sis in tissues is normally limited to individual scattered
cells (Arends and Wyllie, 1991). Sequestration of active ef-
fector caspases may be an important component of the cell
death program required to prevent the spread of cell dam-
age before removal of the apoptotic cell by phagocytosis.
We demonstrate that cytokeratin disassembly and the for-
mation of caspase-associated spheroidal inclusions occurs
after TRAIL-induced apoptosis of lung, cervical, and non-
transformed breast epithelial cells. Therefore, we propose
that this phenomenon may be a characteristic feature of
epithelial cells undergoing apoptosis.
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